Literature DB >> 812929

Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients.

T M Drew, R Altman, K Black, M Goldfield.   

Abstract

A high rate of side effects (mostly vestibular) was found among 83 people receiving prophylaxis with minocycline because of contact with a patient who had died of meningitis due to Neisseria meningitidis. Three groups of contacts received different lots of minocycline and different dosage regimens. Seventy-eight percent of these people had symptoms temporally related to ingestion of minocycline. These symptoms, which included dizziness, nausea, vomiting, vertigo, anorexia, and headache, generally commenced soon after initiation of chemoprophylaxis; the total dosage of minocycline was low. The high rate of vestibular side effects of minocycline militates against widespread use of minocycline for prophylaxis of meningococcal infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 812929     DOI: 10.1093/infdis/133.2.194

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  The effect of minocycline on potassium leakage from red cells: a study of the genetics and relationship to vestibular adverse reactions.

Authors:  B G Lannigan; D A Evans
Journal:  J Med Genet       Date:  1982-10       Impact factor: 6.318

3.  Minocycline development for acute ischemic stroke.

Authors:  Susan C Fagan; Lydia E Cronic; David C Hess
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

4.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

5.  Molecular characterization of rifampin-resistant Neisseria meningitidis.

Authors:  P E Carter; F J Abadi; D E Yakubu; T H Pennington
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 6.  Minocycline for short-term neuroprotection.

Authors:  Hazem F Elewa; Hend Hilali; David C Hess; Livia S Machado; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2006-04       Impact factor: 4.705

7.  Meningococcal disease in California. Epidemiology and management.

Authors:  C Juels; F R Morrison; G D Overturf; R R Roberto; J C Chin
Journal:  West J Med       Date:  1978-03

8.  Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury.

Authors:  Nguyen Mai; Sara A Knowlden; Kathleen Miller-Rhodes; Viollandi Prifti; Max Sims; Mark Grier; Mark Nelson; Marc W Halterman
Journal:  Exp Mol Pathol       Date:  2020-12-29       Impact factor: 4.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.